Carregant...
The Introduction of Generic Aromatase Inhibitors and Treatment Adherence Among Medicare D Enrollees
BACKGROUND: Aromatase inhibitors (AIs) substantially reduce breast cancer mortality in clinical trials, but high rates of nonadherence to these long-term oral therapies have reduced their impact outside of trials. We examined the association of generic AI availability with AI adherence among a large...
Guardat en:
| Publicat a: | J Natl Cancer Inst |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4580559/ https://ncbi.nlm.nih.gov/pubmed/25971298 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djv130 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|